GenSci144 tablet safety study for healthy volunteers
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This trial tests the safety of a new tablet called GenSci144 in healthy adults. It helps doctors see if the drug is safe and how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26.
- You weigh at least 110 lbs (50 kg) if you're a man, or 99 lbs (45 kg) if you're a woman.
- You are willing to use effective birth control for 3 months after the last dose and not plan pregnancy or donate sperm/eggs.
- You are generally healthy with no major medical conditions like liver, kidney, heart, or stomach problems.
- You do not have a family history of sudden death or serious mental health disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called GenSci161 to see if it is safe and how the body handles it. It is for healthy volunteers aged 18 to 45 who are willing to follow study rules and use birth control.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This trial is testing a new medicine called KHN707 in healthy people. The goal is to see if it is safe and how the body handles it. It is an early-stage study, so it is not intended to treat any condition yet.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
Hear when a new Phenylketonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.